Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexei V Tulin

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Upregulation of PARG in prostate cancer cells suppresses their malignant behavior and downregulates tumor-promoting genesYaroslava Karpova, Sarah J Johnson, Guillaume Bordet, et al.
Molecular Cell|February 11, 2014
Kinase-mediated changes in nucleosome conformation trigger chromatin decondensation via poly(ADP-ribosyl)ationColin J Thomas, Elena Kotova, Mark Andrake, et al.
Oncotarget|February 8, 2014
Minor grove binding ligands disrupt PARP-1 activation pathwaysKirill I Kirsanov, Elena Kotova, Petr Makhov, et al.
Ebiomedicine|October 12, 2016
Non-NAD-Like poly(ADP-Ribose) Polymerase-1 Inhibitors effectively Eliminate Cancer in vivoColin Thomas, Yingbiao Ji, Niraj Lodhi, et al.
Plos Biology|October 17, 2008
The nucleosome-remodeling ATPase ISWI is regulated by poly-ADP-ribosylationAnna Sala, Gaspare La Rocca, Giosalba Burgio, et al.
Genetica|May 2, 2003
Stellate repeats: targets of silencing and modules causing cis-inactivation and trans-activationVladimir A Gvozdev, Alexei A Aravin, Yury A Abramov, et al.
Biochemical Pharmacology|March 19, 2019
Non-NAD-like PARP-1 inhibitors in prostate cancer treatmentYaroslava Karpova, Chao Wu, Ali Divan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2019
Hit and run versus long-term activation of PARP-1 by its different domains fine-tunes nuclear processesColin Thomas, Yingbiao Ji, Chao Wu, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Upregulation of PARG in prostate cancer cells suppresses their malignant behavior and downregulates tumor-promoting genesYaroslava Karpova, Sarah J Johnson, Guillaume Bordet, et al.
Molecular Cell|February 11, 2014
Kinase-mediated changes in nucleosome conformation trigger chromatin decondensation via poly(ADP-ribosyl)ationColin J Thomas, Elena Kotova, Mark Andrake, et al.
Oncotarget|February 8, 2014
Minor grove binding ligands disrupt PARP-1 activation pathwaysKirill I Kirsanov, Elena Kotova, Petr Makhov, et al.
Ebiomedicine|October 12, 2016
Non-NAD-Like poly(ADP-Ribose) Polymerase-1 Inhibitors effectively Eliminate Cancer in vivoColin Thomas, Yingbiao Ji, Niraj Lodhi, et al.
Plos Biology|October 17, 2008
The nucleosome-remodeling ATPase ISWI is regulated by poly-ADP-ribosylationAnna Sala, Gaspare La Rocca, Giosalba Burgio, et al.
Genetica|May 2, 2003
Stellate repeats: targets of silencing and modules causing cis-inactivation and trans-activationVladimir A Gvozdev, Alexei A Aravin, Yury A Abramov, et al.
Biochemical Pharmacology|March 19, 2019
Non-NAD-like PARP-1 inhibitors in prostate cancer treatmentYaroslava Karpova, Chao Wu, Ali Divan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2019
Hit and run versus long-term activation of PARP-1 by its different domains fine-tunes nuclear processesColin Thomas, Yingbiao Ji, Chao Wu, et al.
Pageof 5